RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
34.47
0.00 (-0.01%)
At close: Dec 5, 2025, 4:00 PM EST
33.80
-0.67 (-1.93%)
After-hours: Dec 5, 2025, 5:58 PM EST
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $953.12 million as of December 5, 2025. Its market cap has increased by 2,378.58% in one year.
Market Cap
953.12M
Enterprise Value
800.31M
1-Year Change
2,378.58%
Ranking
Category
Stock Price
$34.47
Market Cap Chart
Since October 31, 2019, RAPT Therapeutics's market cap has increased from $276.64M to $953.12M, an increase of 244.53%. That is a compound annual growth rate of 22.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 955.19M | 347.96% |
| Dec 31, 2024 | 213.23M | -75.05% |
| Dec 29, 2023 | 854.75M | 27.19% |
| Dec 30, 2022 | 672.02M | -38.08% |
| Dec 31, 2021 | 1.09B | 123.77% |
| Dec 31, 2020 | 484.97M | -19.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |